Viewing Study NCT03836066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-02-03 @ 11:26 AM
Study NCT ID: NCT03836066
Status: COMPLETED
Last Update Posted: 2025-12-04
First Post: 2019-02-07
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Atezolizumab Plus Bevacizumab in First Line NSCLC Patients
Sponsor: Fundación GECP
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC, Atezolizumab, Bevacizumab View